Table 3.
ComD1 | ComD2 | |||||
---|---|---|---|---|---|---|
Peptide Number | Peptide Name | Sequence | EC50 (nM)b | 95% CIc | EC50 (nM)b | 95% CIc |
21 | CSP2(15)-I4LR6KL9RF13LL14Q | EMRLSKIIRDFLLQR | >1000 | -- | 141 | 85.5–235 |
22 | CSP2(15)-I4LI7FL9RF13LL14Q | EMRLSRFIRDFLLQR | 266 | 144–492 | >1000 | -- |
23 | CSP2(15)-I4LI8FL9RF13LL14Q | EMRLSRIFRDFLLQR | 75.3 | 59.4–95.4 | 41.0 | 21.2–79.0 |
24 | CSP2(15)-I4LL9RL12IF13LL14Q | EMRLSRIIRDFILQR | >1000 | -- | 158 | 64.5–387 |
See experimental section for detail of reporter strains. See supporting information for methods and plots of agonism dose response curves. All assays were performed in triplicates.
EC50 values were determined by testing peptides over a range of concentrations.
95% confidence interval.